期刊文献+

E1A基因对鼻咽癌细胞放射敏感性影响的初步实验研究 被引量:2

Effect of E1A gene on radiosensitivity of nasopharyngeal carcinoma cells
原文传递
导出
摘要 目的探讨E1A基因对鼻咽癌细胞放射增敏作用及相关机制。从而为提高鼻咽癌放射治疗疗效提供实验依据。方法经腺病毒介导,将E1A基因导入人鼻咽癌细胞系CNE2细胞。经RT-PCR鉴定,获得含E1A的阳性克隆。将未转染的CNE2细胞、转染对照空载体Ad-B-gal的CNE2细胞和转染Ad-E1A的CNE2细胞用6MVX线分别照射0、2、4、6、8Gy后进行成克隆分析并绘制细胞存活曲线,计算放射增敏比。流式细胞术和RT—PCR检测转染前后的细胞周期分布以及wtp53表达情况。结果转染后阳性克隆细胞RT—PCR结果说明E1A已整合到细胞基因组中并且稳定表达。细胞存活曲线结果显示转染E1A的CNE2细胞放射增敏比分别为1.37(D0值比)、1.95(Dq值比)、1.46(SF2值比)。未转染及空载体转染后的CNE2细胞照射后细胞存活曲线分析结果显示无差异,D0、Dq、SF2值分别为1.57Gy及1.53Gy、1.82Gy及1.78Gy、0.89及0.82。流式细胞术显示细胞周期出现G2+M期阻滞,RT-PCR结果显示E1A基因能提高wtp53的表达。结论E1A基因能显著提高人鼻咽癌细胞的放射敏感性,其作用机制可能与E1A基因提高wtp53基因的表达和引起G2+M期阻滞有关。 Objective To study the effect of E1A gene on the radiosensitivity of nasopharyngeal carcinoma (NPC) cells and its mechanism. Methods Ad-E1A gene was transfected into human NPC ceils (CNE2), then the positive clones (CNE2-Ad-E1A) were identified by RT-PCR. CNE2 cells, CNE2 cells transfected with Ad-β-gal (CNE2-Ad -β-gal) and CNE2-Ad-E1A cells were irradiated with 0 Gy,2 Gy,4 Gy,6 Gy and 8 Gy respectively using 6 MV X-ray. Clone forming assays were carried out, cell survival curves were drawn and the sensitivity enhancing ratio (SER) was calculated. The redistributions of cell cycle were analyzed by flow cytometry. RT-PCR was used to detect the expression of wtp53. Results RT- PCR confirmed that E1A gene had been integrated into positively transfected cells and stably expressed. Cell survival curves showed that the SER of Do, Dq and SF2 value was 1.37, 1.95 and 1.46 in CNE2-Ad-E1A cells. The DO ,Dq and SF2 value was 1.57 Gy,1.82 Gy, 0.89 in CNE-2 cells and 1.53 Gy,1.78 Gy,0.82 in CNE2-Ad-lS-gal cells, respectively. The %/M arrest was shown in CNE2-Ad-E1A cells. Moreover, the expression of wtp53 gene was markedly enhanced in Ad-E1A-CNE2 cells. Conclusions E1A gene can effectively enhance the radiosensitivity of human NPC cells, which may be associated the enhancement of wtp53 expression and G2/M arrest.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2009年第6期489-491,共3页 Chinese Journal of Radiation Oncology
基金 国家自然科学基金资助项目(No:30400118)
关键词 细胞系 鼻咽癌 E1A基因 放射增敏 野生型P53 Cell line, nasopharyngeal carcinoma E1 A gene Radiosensitivity Wild type p53
  • 相关文献

参考文献9

  • 1Liu X, Marmorstein R. Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor. Genes Dev,2007,21 : 2711-2716.
  • 2Zhou RR, Jia SF, Zhou Z, et al. Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16. Cancer Gene Ther,2002 ,9 :407-413.
  • 3Itamochi H, Kigawa I, Kanamori Y, et al. Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma:a potential treatment strategy. Mol Cancer Ther,2007 ,6 :227-235.
  • 4Bartholomeusz C, Itamochi H, Nitta M, et al. Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15. Oncogene,2006 ,25 :79-90.
  • 5张大昕,赵清正,余子豪.E1A与凋亡的关系及其对肿瘤放射敏感性的影响[J].中华放射肿瘤学杂志,2000,9(1):64-66. 被引量:1
  • 6廖遇平,丁思娟,周蓉蓉,肖华平.E1A基因对喉癌细胞系放射敏感性的影响及机制的初步实验研究[J].中华放射肿瘤学杂志,2008,17(6):467-469. 被引量:1
  • 7Sanchez PR, Lieonart M, Cajal SR. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1A mutants. Oncogene, 2005,11 : 675-682.
  • 8Lowe SW, Ruley HE, Jacks T, et al. p53-dependent apoptosis modulates the eytotoxieity of anticancer agents. Cell, 2003,74 : 957 -967.
  • 9Chougule PB, Akhtar MS, Akerley W, et al. Chemoradiotherapy for advanced inoperable head and neck cancer: a phase Ⅱ study. Semin Radiat Oncol ,2004,9:58-63.

二级参考文献9

  • 1吴旻.基因治疗研究的历史、现状与未来[J].中国肿瘤生物治疗杂志,1995,2(1):1-6. 被引量:10
  • 2Frisch SM. Antioncogenic effect of adenovincs EIA in human tumer cells. Pr℃ Natl Acad Sci USA,1991,88:177-178.
  • 3Muschel RJ, Soto ED, Mckenna WG, et al. Radiosensitization and apoptosis. Oncogene, 1998,17:3359-3363.
  • 4Weichselbaum RR,Hallahan DE,Bechett MA,et al. Gene therapy targeted by radiation preferentially radiosenstitizes tumor cells. Cancer Res, 1994,54:4266.
  • 5Ueno NT, Bartholomeusz C, Herrmann JL, et al. E1 A-mediated paclitaxel sensitization in Her2/neu-overexpressing ovarian cancer skov3, ipl through apoptosis involving the caspase-3 pathway. Clin Cancer Res ,2000,16:250-259.
  • 6Zips D, Krause M, Hessel F,et al. Experimental study on different combination schedules of VEGF-receptor inhibitor FFK 787/ZK 222584 and fractionated irradiation. Anticancer Res, 2003,23 (5A) :3869-3876.
  • 7McDonnell CO, Holden G,Sheridan ME,et al. Improvement in efficacy of chemoradiotherapy by addition of an antiangiogenic agent in a murine tumor model. J Surg Res ,2004 ,116 :19-23.
  • 8Zhou ZC, Zhou RR, Guan H, et al. E1 A gene therapy inhibits angiagenesis in a Ewing's sarcoma animal model Mol. Cancer Therapeutics,2003,2 : 1313-1319.
  • 9Jia SF,Zhou Z. Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16. Cancer Gene Ther,2002, 9:407-413.

同被引文献4

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部